Moxetumomab pasudotox-tdfk Intravenous and Pramipexole
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Pramipexole and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: pramipexole
Brand name: Mirapex, Mirapex ER
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Pramipexole Dihydrochloride
- Moxetumomab pasudotox-tdfk Intravenous-Pramipexole ER Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Pramipexole Extended-Release Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Pramipexole Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Pramlintide
- Moxetumomab pasudotox-tdfk Intravenous-Pramlintide Acetate
- Pramipexole-Moxifloxacin
- Pramipexole-Moxifloxacin (Systemic)
- Pramipexole-Moxifloxacin Hydrochloride
- Pramipexole-Moxifloxacin Injection
- Pramipexole-Moxifloxacin Intravenous
- Pramipexole-Moxifloxacin Tablets